RATIONALE: Kv1.5 (KCNA5) mediates the ultra-rapid delayed rectifier current that controls atrial action potential duration. Given its atrial-specific expression and alterations in human atrial fibrillation, Kv1.5 has emerged as a promising target for the treatment of atrial fibrillation. A necessary step in the development of novel agents that selectively modulate trafficking pathways is the identification of the cellular machinery controlling Kv1.5 surface density, of which little is yet known. OBJECTIVE: To investigate the role of the unconventional myosin-V (MYO5A and MYO5B) motors in determining the cell surface density of Kv1.5. METHODS AND RESULTS: Western blot analysis showed MYO5A and MYO5B expression in the heart, whereas disruption of endogenous motors selectively reduced IKur current in adult rat cardiomyocytes. Dominant negative constructs and short hairpin RNA silencing demonstrated a role for MYO5A and MYO5B in the surface trafficking of Kv1.5 and connexin-43 but not potassium voltage-gated channel, subfamily H (eag-related), member 2 (KCNH2). Live-cell imaging of Kv1.5-GFP and retrospective labeling of phalloidin demonstrated motility of Kv1.5 vesicles on actin tracts. MYO5A participated in anterograde trafficking, whereas MYO5B regulated postendocytic recycling. Overexpression of mutant motors revealed a selective role for Rab11 in coupling MYO5B to Kv1.5 recycling. CONCLUSIONS: MYO5A and MYO5B control functionally distinct steps in the surface trafficking of Kv1.5. These isoform-specific trafficking pathways determine Kv1.5-encoded IKur in myocytes to regulate repolarizing current and, consequently, cardiac excitability. Therapeutic strategies that manipulate Kv1.5 selective trafficking pathways may prove useful in the treatment of arrhythmias.
RATIONALE: Kv1.5 (KCNA5) mediates the ultra-rapid delayed rectifier current that controls atrial action potential duration. Given its atrial-specific expression and alterations in humanatrial fibrillation, Kv1.5 has emerged as a promising target for the treatment of atrial fibrillation. A necessary step in the development of novel agents that selectively modulate trafficking pathways is the identification of the cellular machinery controlling Kv1.5 surface density, of which little is yet known. OBJECTIVE: To investigate the role of the unconventional myosin-V (MYO5A and MYO5B) motors in determining the cell surface density of Kv1.5. METHODS AND RESULTS: Western blot analysis showed MYO5A and MYO5B expression in the heart, whereas disruption of endogenous motors selectively reduced IKur current in adult rat cardiomyocytes. Dominant negative constructs and short hairpin RNA silencing demonstrated a role for MYO5A and MYO5B in the surface trafficking of Kv1.5 and connexin-43 but not potassium voltage-gated channel, subfamily H (eag-related), member 2 (KCNH2). Live-cell imaging of Kv1.5-GFP and retrospective labeling of phalloidin demonstrated motility of Kv1.5 vesicles on actin tracts. MYO5A participated in anterograde trafficking, whereas MYO5B regulated postendocytic recycling. Overexpression of mutant motors revealed a selective role for Rab11 in coupling MYO5B to Kv1.5 recycling. CONCLUSIONS:MYO5A and MYO5B control functionally distinct steps in the surface trafficking of Kv1.5. These isoform-specific trafficking pathways determine Kv1.5-encoded IKur in myocytes to regulate repolarizing current and, consequently, cardiac excitability. Therapeutic strategies that manipulate Kv1.5 selective trafficking pathways may prove useful in the treatment of arrhythmias.
Authors: Timothy M Olson; Alexey E Alekseev; Xiaoke K Liu; Sungjo Park; Leonid V Zingman; Martin Bienengraeber; Srinivasan Sattiraju; Jeffrey D Ballew; Arshad Jahangir; Andre Terzic Journal: Hum Mol Genet Date: 2006-06-13 Impact factor: 6.150
Authors: T Christ; E Wettwer; N Voigt; O Hála; S Radicke; K Matschke; A Várro; D Dobrev; U Ravens Journal: Br J Pharmacol Date: 2008-06-09 Impact factor: 8.739
Authors: Ye Chen-Izu; Robin M Shaw; Geoffrey S Pitt; Vladimir Yarov-Yarovoy; Jon T Sack; Hugues Abriel; Richard W Aldrich; Luiz Belardinelli; Mark B Cannell; William A Catterall; Walter J Chazin; Nipavan Chiamvimonvat; Isabelle Deschenes; Eleonora Grandi; Thomas J Hund; Leighton T Izu; Lars S Maier; Victor A Maltsev; Celine Marionneau; Peter J Mohler; Sridharan Rajamani; Randall L Rasmusson; Eric A Sobie; Colleen E Clancy; Donald M Bers Journal: J Physiol Date: 2015-03-15 Impact factor: 5.182
Authors: Gary S McDowell; Joan M Lemire; Jean-Francois Paré; Garrett Cammarata; Laura Anne Lowery; Michael Levin Journal: Integr Biol (Camb) Date: 2016-03-14 Impact factor: 2.192
Authors: Kalene R Jasso; Tisianna K Kamba; Arthur D Zimmerman; Ruchi Bansal; Staci E Engle; Thomas Everett; Chang-Hung Wu; Heather Kulaga; Randal R Reed; Nicolas F Berbari; Jeremy C McIntyre Journal: Genesis Date: 2021-06-14 Impact factor: 2.389
Authors: Sabine Charron; François Roubertie; David Benoist; Virginie Dubes; Stephen H Gilbert; Marion Constantin; Delphine Vieillot; Delphine Elbes; Bruno Quesson; Pierre Bordachar; Michel Haissaguerre; Olivier Bernus; Jean-Benoit Thambo; Caroline Rooryck Journal: PLoS One Date: 2015-08-07 Impact factor: 3.240
Authors: Marguerite R Irvin; Colleen M Sitlani; James S Floyd; Bruce M Psaty; Joshua C Bis; Kerri L Wiggins; Eric A Whitsel; Til Sturmer; James Stewart; Laura Raffield; Fangui Sun; Ching-Ti Liu; Hanfei Xu; Adrienne L Cupples; Rikki M Tanner; Peter Rossing; Albert Smith; Nuno R Zilhão; Lenore J Launer; Raymond Noordam; Jerome I Rotter; Jie Yao; Xiaohui Li; Xiuqing Guo; Nita Limdi; Aishwarya Sundaresan; Leslie Lange; Adolfo Correa; David J Stott; Ian Ford; J Wouter Jukema; Vilmundur Gudnason; Dennis O Mook-Kanamori; Stella Trompet; Walter Palmas; Helen R Warren; Jacklyn N Hellwege; Ayush Giri; Christopher O'donnell; Adriana M Hung; Todd L Edwards; Tarunveer S Ahluwalia; Donna K Arnett; Christy L Avery Journal: Am J Hypertens Date: 2019-11-15 Impact factor: 3.080